Overview (11 Jun 2021)
Syngene International Ltd
SYNGENE
INE398R01022

Pharmaceuticals
Result was last declared on 21 Oct 2020
-0.15

Prev. Close
Previous Close
590.85
Current Close
590.7
Current High
596.95
Current Low
588.3
52 Week High
644.55
52 Week Low
346.4
Resistance 1
595.66
Resistance 2
600.63
Support 1
587.01
Support 2
578.36
Std Deviation
1.82%
DMA 200
565.09
DMA 50
578.88
DMA 20
584.78
Fundamentals and Ratios
Standalone
Trailing EPS
10.15
Forwad EPS
11.59
Trailing P/E
58.2
Forward P/E
50.98
PEG Ratio
3.6017
Mkt. Cap (Cr)
Market Cap (Cr)
23628
Total Debt(Cr)
Tot. Debt(Cr)
941.80
Reserve (Cr)
1775.80
Book Value
54.63
P/BV Ratio
10.81
ROCE(%)
16.00
ROE
23.00
Consolidated
Trailing EPS
10.18
Forwad EPS
11.64
Trailing P/E
58.03
Forward P/E
50.75
PEG Ratio
3.54
Mkt. Cap (Cr)
Market Cap (Cr)
23628
Total Debt(Cr)
Tot. Debt(Cr)
941.80
Reserve (Cr)
1775.80
Book Value
54.74
P/BV Ratio
10.79
ROCE(%)
16.00
ROE
23.00

 

Financial Result
Standalone
TypeMar-21Dec-20Sep-20Jun-20Mar-20FY20-21
Revenue658.1584.1517420.2607.32179.4
Other Income18.4017.1013.8015.3020.5064.60
Total Income676.50601.20530.80435.50627.802244.00
Interest6.607.106.607.409.3027.70
Expenditure-519.50-485.30-437.30-369.50-475.20-1811.60
PBDT0.000.000.000.000.000.00
Depreciation-70.00-69.70-68.70-66.10-62.30-274.50
PBT192.00115.9093.5066.00152.60467.40
Tax-31.50-14.10-9.90-8.20-32.60-63.70
Equity0.000.000.000.000.000.00
OPM29.1719.8418.0915.7125.1321.00
Net Profit160.5101.883.657.8120403.7
NPM24.3917.4316.1713.7619.7618
EPS4.032.562.11.463.0210.15
Consolidated
TypeMar-21Dec-20Sep-20Jun-20Mar-20FY20-21
Revenue658.6584.5519.6421.6607.32184.3
Other Income18.4017.1013.8015.3020.5064.60
Total Income677.00601.60533.40436.90627.802248.90
Interest6.607.106.607.409.3027.70
Expenditure-519.80-485.10-439.20-370.60-474.80-1814.70
PBDT0.000.000.000.000.000.00
Depreciation-70.00-69.70-68.70-66.10-62.30-274.50
PBT192.20116.5094.2066.30153.00469.20
Tax-31.60-14.30-10.10-8.30-32.80-64.30
Equity0.000.000.000.000.000.00
OPM28.3919.3717.6615.1824.3720.86
Net Profit160.6102.284.158120.2404.9
NPM23.7216.9915.7713.2819.1518
EPS4.042.572.121.473.0310.18
Annual Reports

Corporate Action
Quarterly Result
Dividend
YearDividend TypeAmountRemarkEx Date
2019Final Dividend0.50Final Dividend - Rs. - 0.500016 Jul 2019
2018Final Dividend1.00Final Dividend - Rs. - 1.000017 Jul 2018
2017Final Dividend1.00Final Dividend - Rs. - 1.000020 Jul 2017
2016Interim Divvidend1.00Interim Dividend - Rs. - 1.000017 Mar 2016
Bonus
YearRatioRemarkEx Date
20191:1Bonus issue 1:111 Jun 2019
Split
Sector: Pharmaceuticals
CompanyCurrent CloseP/E Ratio
AARTIDRUGS
732.85
26.5
ABBOTINDIA
16327.3
50.23
AJANTPHARM
1960.9
25.27
ALBERTDAVD
494.25
14.71
ALEMBICLTD
132.2
254.23
ALKEM
3197.25
22.69
AMBALALSA
43.9
-35.98
ANUHPHR
132.45
23.32
APLLTD
1006.05
16.58
AREYDRG
34.5
13.91
ARMOURPO
162.15
18.47
ASTRAZEN
3780.4
101.3
AUROLAB
111.15
17.07
AUROPHARMA
1009.8
19.01
BAJAJHCARE
696.7
11.57
123456789
Connect @
Important Links
BSE
NSE
Copyright: IndiaOne Media 2020